Rua and Cann reach positive resolution in legal proceedings

Rua Bioscience advises that it has reached a settlement with Cann Group Limited (ASX:CAN), following legal proceedings initiated by Rua in February 2024.

As part of the legal proceedings, both parties undertook mediation which had led to this settlement. Rua Bioscience and Cann Group have executed new supply agreements to support their respective operations in the New Zealand and Australian medicinal cannabis markets. The commercial terms of the settlement are confidential and take effect immediately.

ENDS

• Rua and Cann reach positive resolution in legal proceedings

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Fonterra announces Mainland Group leadership change
OCA - Oceania announces Director changes as part of Board refresh
AIA - Analyst and media webcast for FY26 interim results
The Warehouse Group confirms leaner operating structure
SML - Synlait provides half year performance update
RYM - Refreshed strategy and new capital management framework
ENS - Clarification of Gina Tuzcet’s status
BGP - 4th Quarter Sales to 25 January 2026
Contact Energy 2026 Half Year Results Presentation
February 2nd Morning Report